These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 16042890)

  • 21. Association with 5'-untranslated region and response to interferon in chronic hepatitis C.
    Katano Y; Hayashi K; Ishigami M; Itoh A; Hirooka Y; Nakano I; Goto H
    Hepatogastroenterology; 2007; 54(75):854-7. PubMed ID: 17591078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Using evolutionary tools to refine the new hypervariable region 3 within the envelope 2 protein of hepatitis C virus.
    Torres-Puente M; Cuevas JM; Jiménez-Hernández N; Bracho MA; García-Robles I; Wrobel B; Carnicer F; del Olmo J; Ortega E; Moya A; González-Candelas F
    Infect Genet Evol; 2008 Jan; 8(1):74-82. PubMed ID: 18063425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of TLR7 single nucleotide polymorphisms with chronic HCV-infection and response to interferon-a-based therapy.
    Schott E; Witt H; Neumann K; Bergk A; Halangk J; Weich V; Müller T; Puhl G; Wiedenmann B; Berg T
    J Viral Hepat; 2008 Jan; 15(1):71-8. PubMed ID: 18088248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thalidomide in the treatment of chronic hepatitis C unresponsive to alfa-interferon and ribavirin.
    Milazzo L; Biasin M; Gatti N; Piacentini L; Niero F; Zanone Poma B; Galli M; Moroni M; Clerici M; Riva A
    Am J Gastroenterol; 2006 Feb; 101(2):399-402. PubMed ID: 16454849
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of lipid profiles with hepatitis C viral load in chronic hepatitis C patients with genotype 1 or 2 infection.
    Hsu CS; Liu CH; Liu CJ; Wang CC; Chen CL; Lai MY; Chen PJ; Chen DS; Kao JH
    Am J Gastroenterol; 2009 Mar; 104(3):598-604. PubMed ID: 19262519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relapse of hepatitis C virus-associated mixed cryoglobulinemia vasculitis in patients with sustained viral response.
    Landau DA; Saadoun D; Halfon P; Martinot-Peignoux M; Marcellin P; Fois E; Cacoub P
    Arthritis Rheum; 2008 Feb; 58(2):604-11. PubMed ID: 18240235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interferon regulatory factor-1 promoter polymorphism and the outcome of hepatitis C virus infection.
    Wietzke-Braun P; Maouzi AB; Mänhardt LB; Bickeböller H; Ramadori G; Mihm S
    Eur J Gastroenterol Hepatol; 2006 Sep; 18(9):991-7. PubMed ID: 16894313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tolerance and efficacy of interferon-alpha in hemodialysis patients in Tripoli.
    Buargub M; El Huni S; Tagdi M
    Saudi J Kidney Dis Transpl; 2006 Sep; 17(3):338-43. PubMed ID: 16970253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of hepatitis C virus in platelets: evaluating its relationship to antiviral therapy outcome.
    de Almeida AJ; Campos-de-Magalhães M; Brandão-Mello CE; de Oliveira RV; do Espirito-Santo MP; Yoshida CF; Lampe E
    Hepatogastroenterology; 2009; 56(90):429-36. PubMed ID: 19579615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Phase I/II study evaluating escalating doses of recombinant human albumin-interferon-alpha fusion protein in chronic hepatitis C patients who have failed previous interferon-alpha-based therapy.
    Balan V; Nelson DR; Sulkowski MS; Everson GT; Lambiase LR; Wiesner RH; Dickson RC; Post AB; Redfield RR; Davis GL; Neumann AU; Osborn BL; Freimuth WW; Subramanian GM
    Antivir Ther; 2006; 11(1):35-45. PubMed ID: 16518958
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Chronic hepatitis C: virologic and immunologic aspects].
    Moriya K; Koike K
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):405-7. PubMed ID: 15359831
    [No Abstract]   [Full Text] [Related]  

  • 32. [The heterogeneity of HCV quasi-species in the hypervariable region and its relationship to interferon therapy].
    Shi LL; Zhang L; Zhao GZ; Qiao GY
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jul; 13(7):523, 527. PubMed ID: 16042890
    [No Abstract]   [Full Text] [Related]  

  • 33. Changes in hypervariable region 1 of the envelope 2 glycoprotein of hepatitis C virus in children and adults with humoral immune defects.
    Gaud U; Langer B; Petropoulou T; Thomas HC; Karayiannis P
    J Med Virol; 2003 Mar; 69(3):350-6. PubMed ID: 12526045
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Different viral kinetics between hepatitis C virus genotype 1 and 2 as on-treatment predictors of response to a 24-week course of high-dose interferon-alpha plus ribavirin combination therapy.
    Yu ML; Chuang WL; Dai CY; Lee LP; Hsieh MY; Lin ZY; Chen SC; Hsieh MY; Wang LY; Chang WY; Tsai SL; Kuo HT
    Transl Res; 2006 Sep; 148(3):120-7. PubMed ID: 16938649
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation between translation efficiency and outcome of combination therapy in chronic hepatitis C genotype 3.
    Yasmeen A; Hamid S; Granath FN; Lindström H; Elliott RM; Siddiqui AA; Persson MA
    J Viral Hepat; 2006 Feb; 13(2):87-95. PubMed ID: 16436126
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical significance of in vitro replication-enhancing mutations of the hepatitis C virus (HCV) replicon in patients with chronic HCV infection.
    Sarrazin C; Mihm U; Herrmann E; Welsch C; Albrecht M; Sarrazin U; Traver S; Lengauer T; Zeuzem S
    J Infect Dis; 2005 Nov; 192(10):1710-9. PubMed ID: 16235168
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.